APP and APP/PS1 mice are commonly used amyloidosis models due to their rapid Aβ plaque accumulation, though they lack significant neurodegeneration and tau pathology (Radde et al., 2006; Serneels et al., 2020). The gene discussed is MAPT; the disease is amyloidosis.